(Q34292437)

English

Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

anti-retroviral agent

0 references

0 references

Salome Charalambous

3

object named as

Salome Charalambous

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Katherine L Fielding

2

object named as

Katherine Fielding

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7

object named as

Alison D Grant

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gavin J Churchyard

5

object named as

Gavin Churchyard

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Victoria Johnston

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Mildred Mampho

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Andrew Phillips

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

29 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

e36997

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

copyright license

Creative Commons Attribution 4.0 International

29 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: a qualitative assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Outcomes after virologic failure of first-line ART in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Mortality after failure of antiretroviral therapy in sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

The impact of gender and income on survival and retention in a South African antiretroviral therapy programme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Mortality and loss to follow-up among HAART initiators in rural South Africa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Antiretroviral therapy and early mortality in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

"That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

A modified poisson regression approach to prospective studies with binary data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362581

6 July 2018

Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Establishing a workplace antiretroviral therapy programme in South Africa

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Older age and the response to and tolerability of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

Adherence is not a barrier to successful antiretroviral therapy in South Africa

2 references

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0036997

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/22666338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Public-sector ART in the Free State Province, South Africa: Community support as an important determinant of outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22666338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART

1 reference

https://pubmed.ncbi.nlm.nih.gov/22666338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0036997

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2012PLoSO...736997J

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34292437&oldid=2121890916"